{
"main_header": {
"sid": 1002771,
"name": "ERIS Lifescience",
"stock_name": "ERIS Lifescience",
"full_name": "ERIS Lifesciences Ltd",
"name_url": "stocks-analysis/eris-lifescience",
"exchange": 0,
"exchangecode": "",
"country_id": 34,
"currency": "INR",
"cmp": "1,321.35",
"chg": 9.7,
"chgp": "0.74%",
"dir": 1,
"prev_price": "1,311.65",
"mcapval": "17,749.00 Cr",
"mcap": "Small Cap",
"scripcode": 540596,
"symbol": "ERIS",
"ind_name": "Pharmaceuticals & Biotechnology",
"ind_code": 4,
"indexname": "",
"isin": "INE406M01024",
"curr_date": "Apr 02",
"curr_time": "",
"bse_nse_vol": "21.2 k",
"exc_status": "Active",
"traded_date": "Apr 02, 2026",
"traded_date_str": "2026 04 02",
"score": "",
"scoreText": "",
"Live": 0,
"market_time": 1,
"is_blur": 1,
"is_blur_class": "blur-registerF-score-header",
"is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/eris-lifescience-1002771-0&utm_source=Spage_Header_Score",
"mojoone": {
"ismore": 0
}
},
"news": {
"results": [],
"total": 0,
"sid": "1002771",
"stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/eris-lifesciences-1002771"
},
"announcements": [
{
"caption": "Closure Of The Transaction Related To Acquisition Of Probiotics Business Of Velbiom Probiotics Private Limited.",
"datetime": "31-Mar-2026",
"details": "As Attached",
"source": "BSE"
},
{
"caption": "Corporate Guarantee",
"datetime": "27-Mar-2026",
"details": "as attached",
"source": "BSE"
},
{
"caption": "Closure of Trading Window",
"datetime": "27-Mar-2026",
"details": "As Attached",
"source": "BSE"
}
],
"corporate_actions": [
{
"img": "board-meeting.svg",
"title": "BOARD MEETING",
"msg": "<span>No</span> Upcoming Board Meetings",
"data": []
},
{
"img": "dividend.svg",
"title": "DIVIDEND",
"msg": "",
"data": [
{
"txt": "ERIS Lifesciences Ltd has declared <strong>735%</strong> dividend, ex-date: 13 Feb 25",
"dt": "2025-02-13",
"middle_text": "Dividend Alert"
}
]
},
{
"img": "splits.svg",
"title": "SPLITS",
"msg": "No <strong>Splits</strong> history available",
"data": []
},
{
"img": "bonus.svg",
"title": "BONUS",
"msg": "No <strong>Bonus</strong> history available",
"data": []
},
{
"img": "rights-issues.svg",
"title": "RIGHTS",
"msg": "No <strong>Rights</strong> history available",
"data": []
}
]
}Closure Of The Transaction Related To Acquisition Of Probiotics Business Of Velbiom Probiotics Private Limited.
31-Mar-2026 | Source : BSEAs Attached
Corporate Guarantee
27-Mar-2026 | Source : BSEas attached
Closure of Trading Window
27-Mar-2026 | Source : BSEAs Attached
Corporate Actions
No Upcoming Board Meetings
ERIS Lifesciences Ltd has declared 735% dividend, ex-date: 13 Feb 25
No Splits history available
No Bonus history available
No Rights history available
Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)
Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013
For queries or grievances, please contact us on support@mojoinfinity.com, Phone : 022-35121239
"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."